{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:14:52Z","timestamp":1790946892917,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In cells and tissues resistin affects IL-1\u03b2, IL-6, IL-8, IL-12 and TNF-\u03b1 expression, thus suggesting the existence of a multi-cytokine \u201cresistin pathway\u201d. We investigated whether such pathway does exist in humans and, if so, if it is associated with cardiovascular risk factors and with major adverse cardiovascular events (MACE). Serum cytokines were measured in 280 healthy subjects from the Gargano Study 2 (GS2) whose BMI, waist circumference, HOMA<jats:sub>IR<\/jats:sub>, triglycerides, HDL-cholesterol, systolic and diastolic blood pressure data were available and in 353 patients with type 2 diabetes and coronary artery disease from the Gargano Heart Study (GHS)-prospective design (follow-up 5.4\u2009\u00b1\u20092.5 years; 71 MACE). In GS2, cytokines mRNA levels in white blood cells were also measured. In GS2, resistin mRNA was correlated with all cytokines expression (all p\u2009&lt;\u20090.001), but IL-12B. Consistently, serum resistin was correlated with all serum cytokines (all p\u2009&lt;\u20090.001), but IL-12. Expression (eRPS) and serum (sRPS) resistin pathway scores (excluding IL-12) were each other correlated (p\u2009&lt;\u20090.001) and both associated with cardiovascular risk factors (all p\u2009&lt;\u20090.01). In GHS, sRPS was independently associated with MACE (HR\u2009=\u20091.44, 95% CI\u2009=\u20091.10\u20131.90). Our data indicate the existence of a resistin pathway, which is associated with cardiovascular risk factors and which strongly and independently predicts MACE.<\/jats:p>","DOI":"10.1038\/srep44337","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T10:07:54Z","timestamp":1489486074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals"],"prefix":"10.1038","volume":"7","author":[{"given":"Claudia","family":"Menzaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"De Bonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Ortega Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Salvemini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Copetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Trischitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"BFsrep44337_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.108.846519","volume":"120","author":"SR Preis","year":"2009","unstructured":"Preis, S. R. et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 120, 212\u2013220 (2009).","journal-title":"Circulation"},{"key":"BFsrep44337_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/cir.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian, D. et al. Executive Summary: Heart Disease and Stroke Statistics\u20132016 Update: A Report From the American Heart Association. Circulation 133, 447\u2013454, doi: 10.1161\/cir.0000000000000366 (2016).","journal-title":"Circulation"},{"key":"BFsrep44337_CR3","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman, J. A., Creager, M. A. & Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287, 2570\u20132581 (2002).","journal-title":"JAMA"},{"key":"BFsrep44337_CR4","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","volume":"97","author":"SM Haffner","year":"2006","unstructured":"Haffner, S. M. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. The American journal of cardiology 97, 3A\u201311A (2006).","journal-title":"The American journal of cardiology"},{"key":"BFsrep44337_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2337\/db16-0339","volume":"65","author":"PE Scherer","year":"2016","unstructured":"Scherer, P. E. The Multifaceted Roles of Adipose Tissue-Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture. Diabetes 65, 1452\u20131461, doi: 10.2337\/db16-0339 (2016).","journal-title":"Diabetes"},{"key":"BFsrep44337_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.02.014","volume":"182","author":"MS Burnett","year":"2005","unstructured":"Burnett, M. S. et al. The potential role of resistin in atherogenesis. Atherosclerosis 182, 241\u2013248 (2005).","journal-title":"Atherosclerosis"},{"key":"BFsrep44337_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly, M. P. et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932\u2013939 (2005).","journal-title":"Circulation"},{"key":"BFsrep44337_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2710.2007.00832.x","volume":"32","author":"G Lupattelli","year":"2007","unstructured":"Lupattelli, G. et al. Endothelial dysfunction in vivo is related to monocyte resistin mRNA expression. Journal of clinical pharmacy and therapeutics 32, 373\u2013379 (2007).","journal-title":"Journal of clinical pharmacy and therapeutics"},{"key":"BFsrep44337_CR9","first-page":"H746","volume":"298","author":"S Langheim","year":"2010","unstructured":"Langheim, S. et al. Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. American journal of physiology 298, H746\u2013753 (2010).","journal-title":"American journal of physiology"},{"key":"BFsrep44337_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1475-2840-8-60","volume":"8","author":"H Osawa","year":"2009","unstructured":"Osawa, H. et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovascular diabetology 8, 60 (2009).","journal-title":"Cardiovascular diabetology"},{"key":"BFsrep44337_CR11","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2007-2735","volume":"93","author":"C Weikert","year":"2008","unstructured":"Weikert, C. et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 93, 2647\u20132653 (2008).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep44337_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jacc.2008.07.073","volume":"53","author":"DS Frankel","year":"2009","unstructured":"Frankel, D. S. et al. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 53, 754\u2013762 (2009).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep44337_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/ATVBAHA.109.186783","volume":"29","author":"J Butler","year":"2009","unstructured":"Butler, J. et al. Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study. Arteriosclerosis, thrombosis, and vascular biology 29, 1144\u20131149 (2009).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep44337_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2007.07.001","volume":"386","author":"G Hoefle","year":"2007","unstructured":"Hoefle, G. et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clinica chimica acta; international journal of clinical chemistry 386, 1\u20136 (2007).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"BFsrep44337_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ijo.2009.204","volume":"34","author":"G Luc","year":"2010","unstructured":"Luc, G. et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond) 34, 118\u2013126 (2010).","journal-title":"Int J Obes (Lond)"},{"key":"BFsrep44337_CR16","doi-asserted-by":"publisher","first-page":"e64729","DOI":"10.1371\/journal.pone.0064729","volume":"8","author":"C Menzaghi","year":"2014","unstructured":"Menzaghi, C. et al. Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. PLoS One 8, e64729, doi: 10.1371\/journal.pone.0064729 (2014).","journal-title":"PLoS One"},{"key":"BFsrep44337_CR17","doi-asserted-by":"publisher","first-page":"e0120419","DOI":"10.1371\/journal.pone.0120419","volume":"10","author":"A Fontana","year":"2015","unstructured":"Fontana, A. et al. Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis. PLoS One 10, e0120419, doi: 10.1371\/journal.pone.0120419 (2015).","journal-title":"PLoS One"},{"key":"BFsrep44337_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2006.10.023","volume":"378","author":"SP Efstathiou","year":"2007","unstructured":"Efstathiou, S. P. et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clini Chim Acta 378, 78\u201385, doi: S0009-8981(06)00712-1 [pii] 10.1016\/j.cca.2006.10.023 (2007).","journal-title":"Clini Chim Acta"},{"key":"BFsrep44337_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2006.11.017","volume":"196","author":"S Lim","year":"2008","unstructured":"Lim, S. et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis 196, 398\u2013404 (2008).","journal-title":"Atherosclerosis"},{"key":"BFsrep44337_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2006.05.039","volume":"193","author":"E Lubos","year":"2007","unstructured":"Lubos, E. et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 193, 121\u2013128 (2007).","journal-title":"Atherosclerosis"},{"key":"BFsrep44337_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2265.2007.02743.x","volume":"66","author":"S Pilz","year":"2007","unstructured":"Pilz, S. et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxf) 66, 380\u2013386 (2007).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFsrep44337_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cmet.2014.01.013","volume":"19","author":"S Lee","year":"2014","unstructured":"Lee, S. et al. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab 19, 484\u2013497, doi: 10.1016\/j.cmet.2014.01.013 (2014).","journal-title":"Cell Metab"},{"key":"BFsrep44337_CR23","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U. & Tarkowski, A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174, 5789\u20135795 (2005).","journal-title":"J Immunol"},{"key":"BFsrep44337_CR24","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1371\/journal.pone.0000031","volume":"1","author":"I Nagaev","year":"2006","unstructured":"Nagaev, I., Bokarewa, M., Tarkowski, A. & Smith, U. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One 1, e31, doi: 10.1371\/journal.pone.0000031 (2006).","journal-title":"PLoS One"},{"key":"BFsrep44337_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","volume":"334","author":"N Silswal","year":"2005","unstructured":"Silswal, N. et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochemical and biophysical research communications 334, 1092\u20131101, doi: 10.1016\/j.bbrc.2005.06.202 (2005).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep44337_CR26","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.3748\/wjg.v19.i28.4475","volume":"19","author":"ZX Dong","year":"2013","unstructured":"Dong, Z. X. et al. Resistin mediates the hepatic stellate cell phenotype. World J Gastroenterol 19, 4475\u20134485, doi: 10.3748\/wjg.v19.i28.4475 (2013).","journal-title":"World J Gastroenterol"},{"key":"BFsrep44337_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00592-014-0696-6","volume":"52","author":"A Marucci","year":"2015","unstructured":"Marucci, A. et al. Sex-specific effect of BMI on insulin sensitivity and TNF-\u03b1 expression. Acta Diabetol 52, 413\u2013416, doi: 10.1007\/s00592-014-0696-6 (2015).","journal-title":"Acta Diabetol"},{"key":"BFsrep44337_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12020-015-0705-8","volume":"53","author":"A Marucci","year":"2016","unstructured":"Marucci, A., Mangiacotti, D., Trischitta, V. & Di Paola, R. GALNT2 mRNA levels are associated with serum triglycerides in humans. Endocrine 53, 331\u2013334, doi: 10.1007\/s12020-015-0705-8 (2016).","journal-title":"Endocrine"},{"key":"BFsrep44337_CR29","doi-asserted-by":"publisher","first-page":"e70159","DOI":"10.1371\/journal.pone.0070159","volume":"8","author":"A Marucci","year":"2013","unstructured":"Marucci, A. et al. GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia. PLoS One 8, e70159, doi: 10.1371\/journal.pone.0070159 (2013).","journal-title":"PLoS One"},{"key":"BFsrep44337_CR30","doi-asserted-by":"publisher","first-page":"e38414","DOI":"10.1371\/journal.pone.0038414","volume":"7","author":"C Menzaghi","year":"2012","unstructured":"Menzaghi, C. et al. Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals. PLoS One 7, e38414, doi: 10.1371\/journal.pone.0038414 (2012).","journal-title":"PLoS One"},{"key":"BFsrep44337_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2014.10.005","volume":"237","author":"C Menzaghi","year":"2014","unstructured":"Menzaghi, C. et al. Joint effect of insulin signaling genes on all-cause mortality. Atherosclerosis 237, 639\u2013644, doi: 10.1016\/j.atherosclerosis.2014.10.005 (2014).","journal-title":"Atherosclerosis"},{"key":"BFsrep44337_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-014-0130-y","volume":"13","author":"C Menzaghi","year":"2014","unstructured":"Menzaghi, C. et al. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovascular diabetology 13, 130, doi: 10.1186\/s12933-014-0130-y (2014).","journal-title":"Cardiovascular diabetology"},{"key":"BFsrep44337_CR33","doi-asserted-by":"crossref","unstructured":"Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.0031-0031.0011 (2002).","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"BFsrep44337_CR34","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1210\/jc.2005-2715","volume":"91","author":"C Menzaghi","year":"2006","unstructured":"Menzaghi, C. et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91, 2792\u20132795 (2006).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep44337_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","volume":"41","author":"RM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien, R. M. A Caution Regarding Rules of Thumb for Variance Inflation Factors. Quality & Quantity 41, 673\u2013690, doi: 10.1007\/s11135-006-9018-6 (2007).","journal-title":"Quality & Quantity"},{"key":"BFsrep44337_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1530\/eje-09-0555","volume":"162","author":"JL Fargnoli","year":"2010","unstructured":"Fargnoli, J. L. et al. Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 162, 281\u2013288, doi: 10.1530\/eje-09-0555 (2010).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep44337_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/eje-08-0427","volume":"159","author":"Q Qi","year":"2008","unstructured":"Qi, Q. et al. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol 159, 585\u2013593, doi: 10.1530\/eje-08-0427 (2008).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep44337_CR38","doi-asserted-by":"publisher","first-page":"11231","DOI":"10.18632\/oncotarget.3591","volume":"6","author":"SK Deshmukh","year":"2015","unstructured":"Deshmukh, S. K. et al. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget 6, 11231\u201311241, doi: 10.18632\/oncotarget.3591 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep44337_CR39","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","volume":"27","author":"GK Shetty","year":"2004","unstructured":"Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S. & Veves, A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes care 27, 2450\u20132457 (2004).","journal-title":"Diabetes care"},{"key":"BFsrep44337_CR40","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.metabol.2006.06.020","volume":"55","author":"J Janowska","year":"2006","unstructured":"Janowska, J., Zahorska-Markiewicz, B. & Olszanecka-Glinianowicz, M. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Metabolism 55, 1495\u20131499, doi: 10.1016\/j.metabol.2006.06.020 (2006).","journal-title":"Metabolism"},{"key":"BFsrep44337_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcrc.2012.04.007","volume":"27","author":"DA Vassiliadi","year":"2012","unstructured":"Vassiliadi, D. A. et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care 27, 400\u2013409, doi: 10.1016\/j.jcrc.2012.04.007 (2012).","journal-title":"J Crit Care"},{"key":"BFsrep44337_CR42","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1093\/hmg\/dds300","volume":"21","author":"Q Qi","year":"2012","unstructured":"Qi, Q. et al. Genome-wide association analysis identifies TYW3\/CRYZ and NDST4 loci associated with circulating resistin levels. Hum Mol Genet 21, 4774\u20134780, doi: 10.1093\/hmg\/dds300 (2012).","journal-title":"Hum Mol Genet"},{"key":"BFsrep44337_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1159\/000345045","volume":"5","author":"P Marques-Vidal","year":"2012","unstructured":"Marques-Vidal, P. et al. Association between inflammatory and obesity markers in a Swiss population-based sample (CoLaus Study). Obes Facts 5, 734\u2013744, doi: 10.1159\/000345045 (2012).","journal-title":"Obes Facts"},{"key":"BFsrep44337_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2265.2012.04384.x","volume":"78","author":"P Marques-Vidal","year":"2013","unstructured":"Marques-Vidal, P. et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf) 78, 232\u2013241, doi: 10.1111\/j.1365-2265.2012.04384.x (2013).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFsrep44337_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/jhh.2012.12","volume":"27","author":"M Pruijm","year":"2013","unstructured":"Pruijm, M. et al. Inflammatory markers and blood pressure: sex differences and the effect of fat mass in the CoLaus Study. J Hum Hypertens 27, 169\u2013175, doi: 10.1038\/jhh.2012.12 (2013).","journal-title":"J Hum Hypertens"},{"key":"BFsrep44337_CR46","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1038\/ncomms9570","volume":"6","author":"MJ Peters","year":"2015","unstructured":"Peters, M. J. et al. The transcriptional landscape of age in human peripheral blood. Nat Commun 6, 8570, doi: 10.1038\/ncomms9570 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep44337_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.7326\/0003-4819-153-7-201010050-00005","volume":"153","author":"S Rosenberg","year":"2010","unstructured":"Rosenberg, S. et al. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med 153, 425\u2013434, doi: 10.7326\/0003-4819-153-7-201010050-00005 (2010).","journal-title":"Ann Intern Med"},{"key":"BFsrep44337_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/circgenetics.108.782730","volume":"1","author":"JA Wingrove","year":"2008","unstructured":"Wingrove, J. A. et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet 1, 31\u201338, doi: 10.1161\/circgenetics.108.782730 (2008).","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep44337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44337","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:36:40Z","timestamp":1719099400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep44337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,6,1]]}},"alternative-id":["BFsrep44337"],"URL":"https:\/\/doi.org\/10.1038\/srep44337","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,14]]},"assertion":[{"value":"9 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44337"}}